Individuals Coming Off Slimming Jabs Regain Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

New research indicates that patients who discontinue new weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who end traditional lifestyle regimens.

Findings released in a major health publication shows that while obese people can lose substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such drugs should be informed of the potential of fast rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.

That rate of regain implies a return to original mass within about a year and a half.

Analyzing Therapies

The research, which reviewed 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.

The team note that people who lose weight through diet and exercise typically experience a less rapid creep back—around 0.1 kg a month—after stopping.

Understanding the Fast Regain

Experts believe the mechanism of the drugs explains the amplified weight return.

The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Long-term administration of GLP-1 levels far above than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement results in appetite is uncontrolled, making excessive eating much more probable."

A Lifelong Issue?

Medical guidelines suggest the jabs for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Many experts contend that, considering the likelihood of relapse, the treatment is often ongoing.

This view is echoed by pharmaceutical companies, who note that the results "highlight the long-term nature of obesity," akin to managing diseases like hypertension.

User Experiences

Individuals who have stopped the medication report a sudden resurgence of hunger.

"It was like a trigger activating and I was suddenly ravenous," recalled an individual.

This difficulty is compounded if users have not adopted permanent dietary or behavioural modifications during treatment.

Significant Use

Figures indicate that a significant number of people in the UK have used these injections in the last 12 months, with desire remaining high.

• Adoption is greater among women than men.
• The 40s and 50s age group shows the highest usage rates.
• Many access the medications through private prescriptions rather than public health services.

Finally, researchers emphasize that while the jabs are potent tools for shedding pounds, they are not a magic fix and long-term success hinges on ongoing behavioural changes.